imaradenant



imaradenant

N N N 2 H N F Cl N

SMILES Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1
InChIKey NCWQLHHDGDXIJN-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Molecular weight (Da) 315.1

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

Bioactivities

imaradenant

N N N 2 H N F Cl N

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

Compound is not listed as a drug.